Business Description
Cogstate Ltd
ISIN : AU000000CGS8
Total Employee Number:
249Description
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 82 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 222.57 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 13.12 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 12.4 | |||||
3-Year EPS without NRI Growth Rate | 14.5 | |||||
3-Year FCF Growth Rate | 14 | |||||
3-Year Book Growth Rate | 17.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 25.02 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.19 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.29 | |||||
9-Day RSI | 64.33 | |||||
14-Day RSI | 62.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.97 | |||||
Quick Ratio | 3.97 | |||||
Cash Ratio | 2.65 | |||||
Days Sales Outstanding | 82.11 | |||||
Days Payable | 65.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 1.5 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.74 | |||||
Operating Margin % | 19.13 | |||||
Net Margin % | 20.15 | |||||
EBITDA Margin % | 32.17 | |||||
FCF Margin % | 6.4 | |||||
OCF Margin % | 16.54 | |||||
ROE % | 22.26 | |||||
ROA % | 16.55 | |||||
ROIC % | 32.8 | |||||
3-Year ROIIC % | -88.07 | |||||
ROC (Joel Greenblatt) % | 492.84 | |||||
ROCE % | 27.08 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.26 | |||||
Forward PE Ratio | 22 | |||||
PE Ratio without NRI | 29.26 | |||||
Shiller PE Ratio | 112.14 | |||||
Price-to-Owner-Earnings | 28.95 | |||||
PEG Ratio | 0.28 | |||||
PS Ratio | 5.93 | |||||
PB Ratio | 6.07 | |||||
Price-to-Tangible-Book | 8 | |||||
Price-to-Free-Cash-Flow | 91.67 | |||||
Price-to-Operating-Cash-Flow | 35.71 | |||||
EV-to-EBIT | 19.61 | |||||
EV-to-Forward-EBIT | 18.53 | |||||
EV-to-EBITDA | 16.06 | |||||
EV-to-Revenue | 5.17 | |||||
EV-to-Forward-Revenue | 4.36 | |||||
EV-to-FCF | 80.09 | |||||
Price-to-GF-Value | 1.24 | |||||
Price-to-Projected-FCF | 4.1 | |||||
Price-to-Median-PS-Value | 1.68 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.24 | |||||
Price-to-Graham-Number | 3.29 | |||||
| Price-to-Net-Current-Asset-Value | 9.33 | |||||
| Price-to-Net-Cash | 18.67 | |||||
Earnings Yield (Greenblatt) % | 5.1 | |||||
FCF Yield % | 1.11 | |||||
Forward Rate of Return (Yacktman) % | 21.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cogstate Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 46.084 | ||
| EPS (TTM) (€) | 0.053 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 62.92 | ||
| 14-Day ATR (€) | 0.028644 | ||
| 20-Day SMA (€) | 1.5906 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 1.408 - 1.684 | ||
| Shares Outstanding (Mil) | 169.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cogstate Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cogstate Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cogstate Ltd Frequently Asked Questions
What is Cogstate Ltd(FRA:C4B)'s stock price today?
The current price of FRA:C4B is €1.68. The 52 week high of FRA:C4B is €1.68 and 52 week low is €1.41.
When is next earnings date of Cogstate Ltd(FRA:C4B)?
The next earnings date of Cogstate Ltd(FRA:C4B) is .
Does Cogstate Ltd(FRA:C4B) pay dividends? If so, how much?
Cogstate Ltd(FRA:C4B) does not pay dividend.
Press Release
Articles on Cogstate Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers